3mg of retatrutide Retatrutide 30mg | COA Verified

Two active forms of GLP-1 are generated in the gut and brain: active GLP-1 (7-36) amide and active GLP-1 (7-37) non-amide 10

Preclinical models have shown that GLP-1 analogs suppress hepatic stellate cell activation, the key drivers of fibrogenesis, resulting in reduced collagen deposition and fibrosis (45, 46)

The Guardian also reported on Phase 3 trial results showing substantial average weight loss among adults with obesity or overweight, while noting common gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation

Retatrutide achieves weight loss results comparable to bariatric surgery, with Phase 2 trials showing 24.2% body weight reduction at the highest dose